Tryptophan rich diet as a new approach to study the serotoninergic enteropancreatic axis.

Por Goke, B, Richter, G, Keim, V, Arnold, R
Publicado em 1987

Effects of glucagon-like peptide-1(7–36)amide on motility and sensation of the proximal stomach in humans

Por Schirra, J, Wank, U, Arnold, R, Göke, B, Katschinski, M
Publicado em 2002

Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans.

Por Schirra, J, Sturm, K, Leicht, P, Arnold, R, Göke, B, Katschinski, M
Publicado em 1998

Effects of glucagon-like peptide-1(7-36)amide on antro-pyloro-duodenal motility in the interdigestive state and with duodenal lipid perfusion in humans

Por Schirra, J, Houck, P, Wank, U, Arnold, R, Goke, B, Katschinski, M
Publicado em 2000

Gastric emptying and release of incretin hormones after glucose ingestion in humans.

Por Schirra, J, Katschinski, M, Weidmann, C, Schäfer, T, Wank, U, Arnold, R, Göke, B
Publicado em 1996

Effect of pancreatic atrophy and hypertrophy on the small intestine.

Por Adler, G, Hausmann, W, Elsebach, K, Goke, B, Lorenz-Meyer, H, Herberg, L, Arnold, R
Publicado em 1987

Endogenous glucagon‐like peptide 1 controls endocrine pancreatic secretion and antro‐pyloro‐duodenal motility in humans

Por Schirra, J, Nicolaus, M, Roggel, R, Katschinski, M, Storr, M, Woerle, H J, Göke, B
Publicado em 2006

Suppression of the Nuclear Factor Eny2 Increases Insulin Secretion in Poorly Functioning INS-1E Insulinoma Cells

Por Dames, P., Weise, M., Puff, R., Göke, B., Parhofer, K. G., Seissler, J., Lechner, A.
Publicado em 2012

Glucagon-like peptide-1: a potent regulator of food intake in humans

Por Gutzwiller, J, Goke, B, Drewe, J, Hildebrand, P, Ketterer, S, Handschin, D, Winterhalder, R, Conen, D, Beglinger, C
Publicado em 1999